JPRN-UMIN000034699尚未招募未知
Therapy with macrolide in severe asthmatic patients with peripheral blood neutrophilia: a non-blinded, crossover trial - MSAPN study
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with chronic obstructive lung disease. 2. Patient who smoked within three months. 3. Patients whose attending physician recommends not to participate the study because of comorbidities (i.e. respiratory infection, heart disease, liver disease, and kidney disease) 4. Patients with non-tuberculotic mycobacterial infection. 5. Patients who cannot use clarithromycin: with history of hypersensitivity to clarithromycin; using presently pimozide, Ergotamine Tartrate, Dihydroergotamine Mesilate, Tadalafil, Asunaprevir, Vaniprevir, or Suvorexant; with liver or kidney disease and using presently Colchicine.
研究者
相似试验
进行中（未招募）
1 期
Effect of macrolides on asthma control, airway inflammation and bacterial colonisation in smokers with asthma - Macrolide Asthma StudyMedDRA version: 9.1 Level: LLT Classification code 10003553 Term: AsthmaMedDRA version: 9.1 Level: PT Classification code 10003553 Term: AsthmaasthmaEUCTR2008-007240-34-GBHS Greater Glasgow & Clyde Hospitals & University of Glasgow80
终止
2 期
Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary DiseaseAsthmaChronic Obstructive Pulmonary DiseaseNCT00181272Johns Hopkins University18
进行中（未招募）
1 期
Macrolides in Refractory AsthmaRefractory asthmaMedDRA version: 9.1 Level: LLT Classification code 10003553 Term: AsthmaEUCTR2007-006576-11-GBottingham University
已完成
4 期
Macrolides in refractory asthmaAsthmaRefractory asthmaRespiratoryISRCTN93221282niversity of Nottingham (UK)20
进行中（未招募）
1 期
Asthma prevention in high-risk children by using early corticosteroid interventioFirst acute wheezing episodeEUCTR2015-001077-40-SESt. Olavs Hospital280